19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is ELIGLUSTAT TARTRATE, with a corresponding application number 205494 and regulatory information .
proudly manufactured in the
approval since 2014-08-19
Sanofi's CERDELGA CAPSULE;ORAL, medication with EQ 84MG BASE of ELIGLUSTAT TARTRATE.